Advertisement
Unlikely to be severe, infections are associated with anti-CD20 therapies and fingolimod
A snapshot of our multisite experience in safely maintaining care during COVID-19
Prolonged symptoms of COVID-19 are likely multifactorial
Association highlights importance of the nose in infection
Advertisement
Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services. Policy
Clinical guidance for our most vulnerable patients
Short video animation visually explains how the vaccines work
Three C Study suggests 28-day efficacy window, 600-mg dose
Risk does not end after the acute phase is over.
Links are centered on neuroinflammation and microvascular injury, network medicine study finds
Advertisement
Advertisement